4th Jan 2005 12:00
4 January 2005Shire Pharmaceuticals Group plc (the "Company")The Company announces that it was notified on 31 December 2004 under Sections198 to 202 of the Companies Act that on 31 December 2004 Franklin Resources,Inc. and its affiliates had holdings managed on behalf of investment clients of63,849,370 ordinary shares of ‚£0.05p each in the capital of the Company. Theseholdings represent 13.167 per cent of the issued ordinary share capital of theCompany.T MayCompany SecretaryFor further information please contact:Investor Relations Clƒ©a Rosenfeld +44 1256 894 160 Notes to editorsShire Pharmaceuticals Group plcShire Pharmaceuticals Group plc (Shire) is a global specialty pharmaceuticalcompany with a strategic focus on meeting the needs of the specialist physicianand currently focuses on developing projects and marketing products in theareas of central nervous system (CNS), gastrointestinal (GI) and renaldiseases. Shire has operations in the world's key pharmaceutical markets (US,Canada, UK, France, Italy, Spain and Germany) as well as a specialist drugdelivery unit in the US.For further information on Shire, please visit the Company's website: www.shire.comENDRelated Shares:
Shire